As of 2026-01-02, the Fair Value of Anika Therapeutics Inc (ANIK) is -11.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.61 USD, the upside of Anika Therapeutics Inc is -219.20%.
With the market price of 9.61 USD and our fair value calculation, Anika Therapeutics Inc (ANIK) is not a good investment. Investing in Anika stocks now will result in a potential loss of 219.20%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -24.00 | 4.10 | -14.90 | -82.67 | -56.39 | -34.77 |
| YoY growth | -188.24% | 117.08% | -463.41% | -454.81% | 31.79% | -191.52% |
| Market Cap (mil) | 138.58 |
| P/E | |
| Forward P/E |
| EPS | -2.29 |
| Avg earnings growth rate | -191.52% |
| TTM earnings | -33.04 |